인간 마이크로바이옴 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPBT00002233
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 188
Buy Now

인간 마이크로바이옴 시장은 2021년 7억 1,895만 달러에서 2028년 29억 2,168만 달러에 이를 것으로 예상됩니다. 2021-2028년 동안 22.2%의 CAGR로 성장할 것으로 추정됩니다. 인간의 미생물군은 각 사람이 주로 장내 박테리아를 품고 있는 수조 개의 공생 미생물 세포로 구성됩니다. 박테리아, 곰팡이, 바이러스를 포함한 미생물은 시간이 지남에 따라 축적되는 질병의 원인 물질이며, 장내 서식지는 유전적 활동과 대사 과정을 변형시켜 정상적으로 존재하는 물질과 조직에 대해 비정상적인 면역 반응을 일으킵니다. 인체. 이러한 공생체가 수행하는 역할과 인간 숙주의 건강에 미치는 영향을 이해하기 위해 전 세계적으로 여러 미생물 프로젝트가 시작되었습니다. 인간 마이크로바이옴 시장의 성장은 생활습관병 발병률 증가, 인간 마이크로바이옴 치료에 대한 관심 증가, 메타게노믹스 및 차세대 시퀀싱의 기술 발전 증가와 같은 요인에 기인합니다. 그러나 엄격한 정부 지침과 세부 검사에 대한 지식 부족은 시장 성장을 방해합니다.



Human Microbiome 시장의 수익성 있는 지역



시장 통찰력



생활 습관병 발병률 증가



지난 수십 년 동안 연구자들은 인간 마이크로바이옴과 암, 당뇨병, 비만, 우울증과 같은 생활습관병 사이의 관계에 대한 명확성. 라이프스타일과 사회적 규범의 변화는 삶의 각 단계에서 마이크로바이옴에 영향을 미칩니다. 인간 마이크로바이옴을 변경하면 이러한 생활 습관병을 제거하는 데 도움이 될 수 있습니다. 세계보건기구(WHO)에 따르면 2016년 세계 인구(성인)의 13%가 비만이었다. 인간의 위장관에서 내분비 기관으로 작용하여 구성과 기능이 비만 발달에 기여합니다. 따라서 건강한 기증자의 대변을 환자에게 이식하는 대변/장 미생물군유전체 이식(GMT)은 비만에 대한 잠재적인 치료법입니다.



당뇨병은 21st 세기의 세계적인 건강 비상 사태 중 하나입니다. 국제 당뇨병 연맹(IDF)에 따르면 북미 지역 당뇨병 환자의 수는 2017년 ~4,600만 명에서 2045년까지 6,200만 명으로 증가할 것으로 예상됩니다. 예측 기간. Firmicutes Clostridia의 감소된 수준은 당뇨병 낙산염 생성 박테리아가 있는 환자의 미생물 군집과 Bacteroidetes: Firmicutes의 증가된 비율을 나타냅니다. 따라서, 당뇨병은 프리바이오틱스, 프로바이오틱스 및 대변 이식을 통해 미생물 군집을 변경함으로써 예방 및 치료할 수 있습니다. 따라서 만성 생활습관병의 발생률 증가는 휴먼 마이크로바이옴 시장 성장을 주도하고 있습니다.



제품 기반 통찰력



제품을 기준으로 휴먼 마이크로바이옴 시장은 식품, 의료용 식품으로 분류됩니다. , 프로바이오틱스, 프리바이오틱스, 약물, 진단 장치 및 보충제. 프로바이오틱스 부문은 2021년에 가장 큰 시장 점유율을 차지할 것으로 예상되며, 프리바이오틱스 부문은 예측 기간 동안 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다.



Human Microbiome Market, by Product - 2021 및 2028



보고서 범위



질병 기반 통찰력



인간 마이크로바이옴 시장은 질병별로 당뇨병, 암, 자가면역 질환, 비만, 정신 질환, 및 기타 질병. 인간 마이크로바이옴 시장은 암과 당뇨병과 같은 생활습관병의 발병률 증가로 인해 부상하고 있습니다. 비만 부문은 2021년에 시장에서 가장 큰 점유율을 차지할 것으로 예상되는 반면 당뇨병 부문은 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.



애플리케이션 기반 인사이트



응용 분야별로 인간 마이크로바이옴 시장은 진단과 치료제로 구분됩니다. 치료제 부문은 2021년에 더 큰 시장 점유율을 차지할 것으로 예상되며 예측 기간 동안 더 높은 CAGR을 기록할 것으로 추가로 추정됩니다.



전략적 통찰력



제품 출시 및 승인은 기업이 글로벌 입지와 제품 포트폴리오를 확장하기 위해 일반적으로 채택하는 전략. 휴먼 마이크로바이옴 시장의 기업들은 고객 확대를 위한 협업 전략에 중점을 두고 있으며, 이를 통해 전 세계적으로 브랜드 이름을 유지할 수 있습니다.



휴먼 마이크로바이옴 시장 - 제품별



< ul>
  • 프로바이오틱스

  • 식품

  • 프리바이오틱스

  • 의료 식품

  • 진단 장치

  • 약물

  • li>
  • 보충제


  • Human Microbiome 시장 - 질병별





    • 비만

    • 당뇨병

    • 자가 면역 장애


    • 정신 장애

    • 기타


    Human Microbiome 시장 - 애플리케이션별





    • 치료

    • 진단


    Human Microbiome 시장 – 지역별





    • 북미

      • US
      • 캐나다

      • 멕시코



    • 유럽

      • 프랑스

      • 독일

      • < li>이탈리아
      • 영국

      • 스페인

      • 기타 유럽



    • 아시아 태평양(APAC) < ul>
    • 중국

    • 인도

    • 한국

    • 일본

    • 호주

    • 기타 아시아 태평양



  • 중동 및 아프리카(MEA)

    • 남아프리카

    • 사우디아라비아

    • UAE
    • 중동 및 아프리카의 나머지 지역



  • 중남미(SCAM)

    • 브라질

    • 아르헨티나
    • 나머지 중남미




  • 회사 프로필





    • Rebiotix Inc.

    • Yakult Honsha Co., Ltd.

    • Synthetic Biologics Inc.

    • DuPont

    • MaaT Pharma

    • Eligo Bioscience

    • < li>Merck & Co. Inc
    • AOBiome LLC

    • Kaleido

    • Seres Therapeutics


    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What is the regional analysis in terms of human microbiome market?

    The Asia Pacific human microbiome market is analyzed based on the five major countries such as China, Japan, India, Australia, South Korea, and the rest of Asia Pacific. The Asia Pacific region is expected to be the fastest-growing region among all other regions. The rise in the collaborations among the Asian countries and Western countries for the research activities and the extensive genomic research in China are to likely drive the human microbiome market in the forecast period. In May 2018, The Conference on Human Microbiome and Chronic Disease, hosted by the Institute of Microbiology, Chinese Academy of Sciences and Chinese Society of Biotechnology was held in China National Convention Center at Beijing. The aim was to promote research human microbiome and related technology. Thus, there is a huge potential for human microbiome market in the region during the forecast period owing to the above-mentioned factors.

    What are the driving factors for the human microbiome market across the globe?

    The growth of the human microbiome market is attributed to the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies, and growing technological advancements in metagenomics and next-generation sequencing. However strict government guidelines and lack of knowledge about detailed examination hinders the market growth.

    What is human microbiome?

    The human microbiota consists of the trillions of symbiotic microbial cells harbored by each person, mainly bacteria in the gut. The microbes including bacteria, fungi and viruses are the disease-causing microbes that accumulate over time and changing their gene activity & metabolic processes and resulting in an abnormal immune response against the substances and tissues that normally present in the human body.

    The List of Companies - Human Microbiome Market

    1. Rebiotix Inc.
    2. Yakult Honsha Co., Ltd.
    3. Synthetic Biologics Inc.
    4. DuPont
    5. MaaT Pharma
    6. Eligo Bioscience
    7. Merck & Co. Inc
    8. AOBiome LLC
    9. Kaleido
    10. Seres Therapeutics

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports